Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study

SIMPLE SUMMARY: Cell-free DNA RAS mutation is being increasingly monitored in metastatic colorectal cancer (mCRC) for disease molecular characterization and selecting eligible patients for anti-EGFR initiation and rechallenge. Here, we monitored a homogeneous mCRC RAS wild-type (as per baseline soli...

Descripción completa

Detalles Bibliográficos
Autores principales: Valladares-Ayerbes, Manuel, Garcia-Alfonso, Pilar, Muñoz Luengo, Jorge, Pimentel Caceres, Paola Patricia, Castillo Trujillo, Oscar Alfredo, Vidal-Tocino, Rosario, Llanos, Marta, Llorente Ayala, Beatriz, Limon Miron, Maria Luisa, Salud, Antonieta, Cirera Nogueras, Luis, Garcia-Carbonero, Rocio, Safont, Maria Jose, Falco Ferrer, Esther, Aparicio, Jorge, Vicente Conesa, Maria Angeles, Guillén-Ponce, Carmen, Garcia-Teijido, Paula, Medina Magan, Maria Begoña, Busquier, Isabel, Salgado, Mercedes, Lloansí Vila, Ariadna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776941/
https://www.ncbi.nlm.nih.gov/pubmed/36551560
http://dx.doi.org/10.3390/cancers14246075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776941/
https://www.ncbi.nlm.nih.gov/pubmed/36551560
http://dx.doi.org/10.3390/cancers14246075

Ejemplares similares